Evidence map›Paper›PMID 40836008›Full record

ArticleScientific reports2025

Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Abideen Salako, Adesola Musa, Fehintola Ige, Adam Abdullahi, Ayorinde James, Sabdat Ekama, Oluwatosin Odubela, Ifeoma Idigbe, Olusola Ajibaye, Mazharul Altaf and 35 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors.

Abideen Salako *Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Adesola Musa *Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Fehintola Ige *Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Adam Abdullahi *Department of Medicine and Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, UK.
Ayorinde JamesNigerian Institute of Medical Research, Yaba, Lagos, Nigeria. ayorindejames@gmail.com.
Sabdat EkamaNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Oluwatosin OdubelaNigerian Institute of Medical Research, Yaba, Lagos, Nigeria. odubstosin08@gmail.com.
Ifeoma IdigbeNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Olusola AjibayeNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Mazharul AltafDepartment of Medicine and Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, UK.
Kazeem AdeneyeNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Folahanmi T AkinsoluNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Ifedola OlojoNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Azuka OkwuraiweNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Henry EgharevbaNational Institute for Pharmaceutical Research, Innovation and Development Abuja Federal Capital Territory, Abuja, Nigeria.
Magaret EkpenyongNational Institute for Pharmaceutical Research, Innovation and Development Abuja Federal Capital Territory, Abuja, Nigeria.
Uchenna ElemuwaNational Agency for Food Drug, Administration and Control, Abuja, FCT, Nigeria.
Ifeoma EzenyiNational Institute for Pharmaceutical Research, Innovation and Development Abuja Federal Capital Territory, Abuja, Nigeria.
Fraden BitrusNational Agency for Food Drug, Administration and Control, Abuja, FCT, Nigeria.
Olayemi OdubelaNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Abdulrasheed ObaNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Ganiu IdrisNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Jimoh YusufNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Ibukun AkandeNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Stephine NwaiwuNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Louisa OmaleNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Oluwatobiloba OyewunmiNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Adedoyin AgbabiakaNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Olajumoke EyinadeNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Joy OgunwaleNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Abdullah GarbaNational Primary Health Development Agency, Abuja, Nigeria.
Yahya BelloNational Primary Health Development Agency, Abuja, Nigeria.
Baba MusaDepartment of Medicine/Africa Center of Excellence for Population Health and Policy, Bayero University Kano, Kano, Kano State, Nigeria.
Ogochukwu EzejioforNnamdi Azikiwe University Teaching Hospital, Nnewi, Enugu State, Nigeria.
Ben EjiroDelta State University Teaching Hospital, Oghara, Delta State, Nigeria.
Bamidele IwalokunNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Leah RosenzweigDevelopment Innovation Lab, University of Chicago, Chicago, IL, USA.
Obi AdigweNational Institute for Pharmaceutical Research, Innovation and Development Abuja Federal Capital Territory, Abuja, Nigeria.
Christianah AdeyeyeNational Agency for Food Drug, Administration and Control, Abuja, FCT, Nigeria.
Faisal ShuaibNational Primary Health Development Agency, Abuja, Nigeria.
Witold WicekDevelopment Innovation Lab, University of Chicago, Chicago, IL, USA.
Yohhei HamadaInstitute for Global Health, University College London, London, UK.
Oliver EzechiNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Ravindra GuptaDepartment of Medicine and Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, UK. Rkg20@cam.ac.uk.
Babatunde SalakoNigerian Institute of Medical Research, Yaba, Lagos, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40836008
PMCPMC12368014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.